Apotex Corp.’s Post

I'm looking forward to the Royal Pharmaceutical Society Conference in London on November 10th. There is plenty to discuss, including insightful views on highly relevant topics for pharmacists working across different sectors. I am especially looking forward to hearing more about pharmacy prescribing. #RPSConf23 #pharmacy #pharmacyprescribing

On September 27th at DVAGO's World Pharmacist Day, a compelling discussion will take place on the Collaboration between pharmacies and the pharmaceutical industry in healthcare. 💼 Zakariya Naseeb, Director of Bosch Pharmaceuticals (Pvt) Ltd., brings his expertise as a panelist to explore the optimization of this collaboration. 💡 Learn how this partnership expedites access to innovative medications and elevates patient care. #WorldPharmacistDay #DVAGO #PakistanMostTrustedPharmacy #PharmacyStrengtheningHealthSystems

AscellaHealth’s Executive Vice President of Growth & Strategy, @DonovanQuill is featured in the recent issue of News Medical. In this informative article, Donovan shares insights on the unique challenges associated with bringing new specialty and rare disease pharmaceutical products to market and what steps to take to increase the likelihood of market access and commercialisation success.   Read the entire article here: https://lnkd.in/eSmXTi97

🌍 Recently engaged in an insightful workshop on the "Global Perspective of Pharmacy"! 🌍 Explored diverse aspects of international healthcare systems and cutting-edge pharmaceutical advancements worldwide. Grateful for the opportunity to learn from industry leaders and peers. This workshop has significantly broadened my understanding of global pharmacy practices and inspired me to contribute effectively in this dynamic field. #Pharmacy #GlobalHealthcare #ProfessionalDevelopment

Here's my latest guest column with The Evidence Base® capturing value highlights from March and April.

A new report by the The Association of the British Pharmaceutical Industry (ABPI) highlights the responsibilities that pharmaceutical companies have to ensure they provide accurate information to support high-quality healthcare. Key recommendation to pharma Pharmaceutical companies should ensure healthcare professionals are aware of company resources available to help guide appropriate prescribing, such as personnel in medical information, pharmacovigilance and medical affairs teams. This awareness should be encouraged and facilitated by companies, but without soliciting for enquiries on specific medicines. Key information on medical information is on slide 18 #medicalinformation #pharmaceutical #medicalaffairs #misinformation https://lnkd.in/eZrwRBxF

Don’t forget to join David Alderson, Diana Brixner, Department of Pharmacotherapy, University of Utah College of Pharmacy, USA, Chris Teale, TealeHeath and Sam Mettam, Jazz Pharmaceuticals at #ISOPRAnnual today at 8am, as we meet to discuss and highlight the consequences of the Inflation Reduction Act and Joint Clinical Assessment and the revision of the EU Pharmaceutical Legislation on healthcare systems and R&D. #healtheconomics #healthcare #marketaccess

Kimberly Westrich (Chief Strategy Officer, National Pharmaceutical Council) shares her highlights in US healthcare value and access from March and April 2024. Read at The Evidence Base® #heor #healtheconomics #outcomesresearch #rwe #rwd #realworldevidence #realworlddata #marketaccess #pharma #biopharma #medicalaffairs #hta #healthtechnologyassessment #healthdata #ISPORAnnual

Welcome to the latest edition of our Pharma News and Regulatory News Updates, where we bring you the most significant developments and breakthroughs in the pharmaceutical industry and the latest updates from regulatory agencies worldwide. https://lnkd.in/gPJMhMXn #pharmanews #regulatoryupdates #medicalbreakthroughs #healthcareadvancements #innovationinmedicine #DrugApprovals #VaccineProgress #publichealthmatters #globalhealthcare #patientcare #medicalresearch #healthtech #sciencenews #COVID19Updates #FluVaccine #AlzheimersTreatment #CancerImmunotherapy #HIVtreatment #RareDiseaseTherapy #AntibioticResistance

If you are at #ISPORAnnual US - Today at 8 am don’t forget to join David Alderson, Diana Brixner, Chris Teale and Sam Mettam. They will be discussing the consequences of the Inflation Reduction Act and Joint Clinical Assessment and the revision of the EU Pharmaceutical Legislation on healthcare systems and R&D. #marketacces #HEOR #healtheconomics